GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,856,000 | +300.9% | 31,611 | +113.3% | 0.00% | – |
| Q4 2020 | $1,710,000 | -8.4% | 14,821 | -22.7% | 0.00% | – |
| Q3 2020 | $1,867,000 | -22.9% | 19,175 | -2.9% | 0.00% | – |
| Q2 2020 | $2,422,000 | +26.5% | 19,738 | -9.7% | 0.00% | – |
| Q1 2020 | $1,914,000 | +96.1% | 21,855 | +134.2% | 0.00% | – |
| Q4 2019 | $976,000 | -2.4% | 9,333 | +7.3% | 0.00% | – |
| Q3 2019 | $1,000,000 | -34.1% | 8,694 | -1.3% | 0.00% | – |
| Q2 2019 | $1,518,000 | +7.7% | 8,806 | +5.3% | 0.00% | – |
| Q1 2019 | $1,409,000 | +70.0% | 8,359 | -1.8% | 0.00% | – |
| Q4 2018 | $829,000 | +262.0% | 8,510 | +277.4% | 0.00% | – |
| Q3 2017 | $229,000 | +8.0% | 2,255 | +6.7% | 0.00% | – |
| Q2 2017 | $212,000 | -70.6% | 2,114 | -79.6% | 0.00% | – |
| Q4 2015 | $721,000 | – | 10,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |